Life-threatening GLP-1 overdoses are on the rise
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Life-threatening GLP-1 overdoses are on the rise" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include RAPS.org, WOAI, WIRED and Reuters. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 86d ago.
Quick answers
Why is "Life-threatening GLP-1 overdoses are on the rise" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- FDA cites companies for CGMP violations, telehealth firms for illegally marketing GLP-1 drugs RAPS.org · 91d ago
- POLL: What's causing the spike in weight-loss drug mistakes? WOAI · 91d ago
- I Was Scammed Buying GLP-1s Online. I’m Not Alone WIRED · 91d ago
- US FDA sends 25 letters to telehealth companies over claims on compounded weight-loss drugs Reuters · 91d ago
- Life-threatening GLP-1 overdoses are on the rise New York Post · 91d ago
Topics
Related trends
The weight I lost with GLP-1s came back ‘with taxes’
Recent coverage examines rapid weight regain after discontinuing GLP-1 medications like Ozempic, semaglutide, and tirzepatide.
GLP-1 drugs dubbed ‘fountain of youth’ as doctors share surprising benefits beyond weight loss
GLP-1 drugs are generating intense interest as doctors highlight surprising health benefits beyond mere weight loss.
Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement
Endocrine Society scientific statement shifts obesity treatment focus beyond weight loss to broader health goals.
Popular GLP-1 drugs may trigger a rare, life-threatening brain disorder: study
Recent studies suggest a link between popular GLP-1 weight-loss medications and severe neurological and psychological risks.
From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs
Medical experts and journalists are working to distinguish scientific facts from social media hype regarding side effects of GLP-1 weight loss medications.
Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea A Review
Recent medical reviews examine how popular weight-loss drugs could transform the clinical treatment of obstructive sleep apnea.